Oxidative stress and antioxidants in hypertension–a current review

Current Hypertension Reviews

Volumn 11, Issue 2, 2015, Pages 132-142

  Sinha, Nakshi ^a   Dabla, Pradeep Kumar ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Antioxidants; Cardiovascular diseases; Endothelial dysfunction; Hypertension; Reactive oxygen species (ROS)

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATALASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NORADRENALIN; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; UROTENSIN II; VASCULAR CELL ADHESION MOLECULE 1; XANTHINE OXIDASE; BIOLOGICAL MARKER;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CELL MIGRATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE OXYGEN CONSUMPTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INFLAMMATION; LIPID PEROXIDATION; MITOCHONDRION; MORBIDITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; BLOOD VESSEL; CENTRAL NERVOUS SYSTEM; DISEASE MODEL; DRUG EFFECTS; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; BIOMARKERS; BLOOD VESSELS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; KIDNEY; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84939811288     PISSN: 15734021     EISSN: 18756506     Source Type: Journal    
DOI: 10.2174/1573402111666150529130922     Document Type: Article

References (76)

1. [1] Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress induced cancer. Chem Biol Interact 2006; 160(1): 1-40.
2. [2] Juránek I, Bezek S. Controversy of free radical hypothesis: reactive oxygen species—cause or consequence of tissue injury. Gen Physiol Biophys 2005; 24(3): 263-78.
3. [3] Venereo JR. Daño oxidativo, radicales libres y antioxidantes. Rev Cubana Med Milit 2002; 31(2): 126-33.
4. [4] Jerlich A, Pitt AR, Schaur RJ, Spickett CM. Pathway of phospholipid oxidation by HOCl in human LDL detected by LCMS. Free Radic Biol Med 2000; 28(5): 673-82.
5. [5] Lavi S, Yang EH, Prasad A, et al. The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension 2008; 51(1): 127-33.
6. [6] Johnson F, Giulivi C. Superoxide dismutases and their impact upon human health. Mol Aspects Med 2005; 26(4-5): 340-52.
7. [7] Mendez JI, Nicholson WJ, Taylor WR. SOD isoforms and signaling in blood vessels: evidence for the importance of ROS compartmentalization. Arterioscler Thromb Vasc Biol 2005; 25(5): 887-8.
8. [8] Touyz RM, Briones AM. Reactive oxygen species and vascular biology: implications in human hypertension. Hypertension Res 2011; 34(1): 5-14.
9. [9] Nishino T, Okamoto K, Eger BT, Pai EF, Nishino T. Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J 2008; 275(13): 3278-89.
10. [10] Moens AL, Kass DA. Tetrahydrobiopterin and cardiovascular disease. Arterioscler Thromb Vasc Biol 2006; 26(11): 2439-44.
11. [11] Mayne ST. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research. J Nutr 2003; 133(3): 933S-40.
12. [12] Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 2003; 41: 341-6.
13. [13] Shokoji T, Nishiyama A, Fujisawa Y, et al. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 2003; 41: 266-73.
14. [14] Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 2004; 109: 2357-62.
15. [15] Zalba G, San Jose G, Beaumont FJ, Fortuno MA, Fortuno A, Diez J. Polymorphisms and promoter overactivity of the p22(phox) gene in vascular smooth muscle cells from spontaneously hypertensive rats. Circ Res 2001; 88: 217-22.
16. [16] Moreno MU, San Jose G, Orbe J, et al. Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertension. FEBS Lett 2003; 542: 27-31.
17. [17] Fujii S, Zhang L, Igarashi J, Kosaka H. L-arginine reverses p47phox and gp91phox expression induced by high salt in Dahl rats. Hypertension 2003; 42: 1014-20.
18. [18] Tanito M, Nakamura H, Kwon YW, et al. Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats. Antioxid Redox Signal 2004; 6: 89-97.
19. [19] Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 2003; 41: 341-6.
20. [20] Dobrian AD, Schriver SD, Khraibi AA, Prewitt RL. Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity. Hypertension 2004; 43: 48-56.
21. [21] Wallwork CJ, Parks DA, Schmid-Schonbein GW. Xanthine oxidase activity in the dexamethasone-induced hypertensive rat. Microvasc Res 2003; 66: 30-7.
22. [22] Shokoji T, Nishiyama A, Fujisawa Y, et al. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 2003; 41: 266-73.
23. [23] Badimón L, Martínez-González J. Disfunción endotelial. Rev Esp Cardiol 2006; 6(Supl A): 21-30.
24. [24] Burger D, Touyz RM. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc Hypertens 2012; 6(2): 85-99.
25. [25] Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353(10): 999-1007.
26. [26] Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circulation Res 2001; 89(1): E1-7.
27. [27] Zhou Z, Peng J, Wang C-J, et al. Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide. J Hypertension 2010; 28(5): 931-9.
28. [28] Lin C-P, Lin F-Y, Huang P-H, et al. Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation. Biomed Res Int 2013; 2013: Article ID 845037, 10 pages.
29. [29] Burger D, Touyz RM. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc Hypertens 2012; 6(2): 85-99.
30. [30] Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011; 31(1): 27-33.
31. [31] Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006; 48(2): 180-6.
32. [32] Touyz RM, Schiffrin E. Arterial hypertension, In: Muscle Fundamental Biology and Mechanisms of Disease, Hill J, Ed., vol. 2, pp. 1311-9, Elsevier, San Diego, Calif, USA, 2012.
33. [33] Hool LC, Corry B. Redox control of calcium channels: from mechanisms to therapeutic opportunities. Antioxid Redox Signal 2007; 9(4): 409-35.
34. [34] Tanito M, Nakamura H, Kwon YW, et al. Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats. Antioxid Redox Signal 2004; 6(1): 89-97.
35. [35] Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, Bächler JP. Relationship between oxidative stress and essential hypertension. Hypertens Res 2007; 30(12): 1159-67.
36. [36] Touyz RM, Schiffrin EL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens 2001; 19(7): 1245-54.
37. [37] Yoshida J, Yamamoto K, Mano T, et al. AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure. Hypertension 2004; 43(3): 686-91.
38. [38] Feairheller DL, Brown MD, Park JY, et al. Exercise training, NADPH oxidase p22 phox gene polymorphisms, and hypertension. Med Sci Sports Exerc 2009; 41(7): 1421-8.
39. [39] Lassègue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003; 285(2): 277-97.
40. [40] Laursen JB, Somers M, Kurz S, et al. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 2001; 103(9): 1282-8.
41. [41] Feairheller DL, Brown MD, Park JY, et al. Exercise training, NADPH oxidase p22phox gene polymorphisms, and hypertension. Med Sci Sports Exerc 2009; 41(7): 1421-8.
42. [42] Laakso JT, Teräväinen TL, Martelin E, Vaskonen T, Lapatto R. Renal xanthine oxidoreductase activity during development of hypertension in spontaneously hypertensive rats. J Hypertens 2004; 22(7): 1333-40.
43. [43] Eto Y, Kang D, Hasegawa E, Takeshige K, Minakami S. Succinate-dependent lipid peroxidation and its prevention by reduced ubiquinone in beef heart submitochondrial particles. Arch Biochem Biophys 1992; 295(1): 101-6.
44. [44] Zhou L, Xiang W, Potts J, et al. Reduction in extracellular superoxide dismutase activity in African-American patients with hypertension. Free Radic Biol Med 2006; 41(9): 1384-91.
45. [45] Michel JB, Feron O, Sase K, Prabhakar P, Michel T. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem 1997; 272(41): 25907-12.
46. [46] Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 2003; 278(25): 22546-54.
47. [47] Hitomi H, Kiyomoto H, Nishiyama A. Angiotensin II and oxidative stress. Curr Opin Cardiol 2007; 22(4): 311-5.
48. [48] Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003; 42(6): 1075-81.
49. [49] Pechánová O. Contribution of captopril thiol group to the prevention of spontaneous hypertension. Physiol Res 2007; 56(Suppl 2): 41-8.
50. [50] Gomez-Alamillo C, Juncos LA, Cases A, Haas JA, Romero JC. Interactions between vasoconstrictors and vasodilators in regulating hemodynamics of distinct vascular beds. Hypertension 2003; 42(4): 831-6.
51. [51] Stirrat A, Gallagher M, Douglas SA, et al. Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries. Am J Physiol Heart Circ Physiol 2001; 280(2): 925-8.
52. [52] Kimura S, Zhang GX, Nishiyama A, et al. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension 2005; 45(3): 438-44.
53. [53] Rodrigo R, Passalacqua W, Araya J, Orellana M, Rivera G. Homocysteine and essential hypertension. J Clin Pharmacol 2003; 43(12): 1299-306.
54. [54] Harrison DG, Gongora MC. Oxidative stress and hypertension. Med Clin North Am 2009; 93(3): 621-35.
55. [55] Rodrigo R, Rivera G. Renal damage mediated by oxidative stress: a hypothesis of protective effects of red wine. Free Radic Biol Med 2002; 33(3): 409-22.
56. [56] Zhang C, Hu JJ, Xia M, Boini KM, Brimson C, Li PL. Redox signaling via lipid raft clustering in homocysteine-induced injury of podocytes. Biochim Biophys Acta 2010; 1803(4): 482-91.
57. [57] Costa-Hong V, Bortolotto LA, Jorgetti V, ConsolimColombo F, Krieger EM, Lima JJ. Oxidative stress and endothelial dysfunction in chronic kidney disease. Arq Bras Cardiol 2009; 92(5): 381-6.
58. [58] Zimmerman MC, Dunlay RP, Lazartigues E, et al. Requirementfor Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 2004; 95: 532-9.
59. [59] Campos RR, Bergamaschi CT. Neurotransmissionalterations in central cardiovascular control in experimental hypertension. Curr Hypertens Rev 2006; 2: 193-8.
60. [60] Peterson J, Burmeister MA, Tian X, Stupinski JA, Sharma VA, Davisson RL. Both Nox2- and Nox4-containing NAD(P)H oxidases are required for the full vasopresso effects of angiotensin- II (Ang-II) in the central nervous system. FASEB J 2007; 21: 752.
61. [61] Chan SH, Hsu KS, Huang CC, Wang LL, Ou CC, Chan JY. NADPH oxidase-derived superoxide anion mediates angiotensin IIinduced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ Res 2005; 97: 737-9.
62. [62] Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117-24.
63. [63] Miller ER III, Appel LJ, Risby TH. Effect of dietary patterns on measures of lipid peroxidation: results from a randomized clinical trial. Circulation 1998; 98: 2390-5.
64. [64] Ceriello A, Motz E, Giugliano D. Vitamin C and hypertension. Lancet 2000; 355: 1271-2.
65. [65] Huang HY, Caballero B, Chang S, et al. The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference. Ann Intern Med 2006; 145: 372-85.
66. [66] Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000; 85: 2970-3.
67. [67] Taddei S, Virdis A, Ghiadoni L, et al. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients. Hypertension 1997; 30: 1606-12.
68. [68] Hirata Y, Hayakawa H, Kakoki M, et al. Nitric oxide release from kidneys of hypertensive rats treated with imidapril. Hypertension 1996; 27: 672-8.
69. [69] Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensinconverting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145-53.
70. [70] Dandona P, Karne R, Ghanim H, et al. Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids. Circulation 2000; 101: 122-4.
71. [71] Kakoki M, Hirata Y, Hayakawa H, et al. Effects of vasodilatory - adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney. Hypertension 1999; 33: 467-71.
72. [72] Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 154-60.
73. [73] Lembo G, Vecchione C, Izzo R, et al. Noradrenergic vascular hyperresponsiveness in human hypertension is dependent on oxygen free radical impairment of nitric oxide activity. Circulation 2000; 102: 552-7.
74. [74] Sherman DL, Keaney JF, Jr, Biegelsen ES, et al. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 2000; 35: 936-41.
75. [75] Duffy SJ, Gokce N, Holbrook M, et al. Treatment of hypertension with ascorbic acid. Lancet 1999; 354: 2048-9.
76. [76] Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes and cardiovascular disease? The “Common Soil” hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24: 816-23.